Communiqués NEXGEL, Inc.

Actions

NXGL

US65344E1073

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 28/06/2024			Varia. 5j.	Varia. 1 janv.
2,16 ^USD	-0,69%		+0,47%	+1,41%

27/06	NEXGEL conclut un accord de distribution pour le pansement SilverSeal avec Cintas	MT
27/06	Nexgel, Inc. fournira Silverseal à Cintas Corporation	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

NEXGEL Subsidiary, CG Converting and Packaging, Announces it will Supply SilverSeal to Cintas Corporation	27/06	AQ
NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America	11/06	AQ
NEXGEL Acquires International Beauty Brand, Silly George	16/05	AQ
NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year	13/05	AQ
NEXGEL to Report First Quarter 2024 Financial Results on May 13th	09/05	AQ
NEXGEL to Present at the Aegis Capital Virtual Conference on May 9, 2024	06/05	AQ
NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024	18/04	AQ
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year	01/04	AQ
NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday	27/03	AQ
NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th	21/03	AQ
NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th	04/03	AQ
NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders	21/02	AQ
NEXGEL to Present at The Microcap Conference, January 30th through February 1st	18/01	AQ
NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024	09/01	AQ
NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America	11/12	AQ
NEXGEL Acquires Kenkoderm Psoriasis Skincare Line	05/12	AQ
NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year	13/11	AQ
NEXGEL to Report Third Quarter 2023 Financial Results on November 13th	02/11	AQ
NEXGEL Secures Supply Agreement with AbbVie	30/10/23	AQ
NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd	26/09/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués NEXGEL, Inc.

Actions

NXGL

US65344E1073

Communiqués

Filtres